Coronary Restenosis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2018-07-17
Clinical Trial Update: The Influence Cirrhosis of the Liver on the Coronary Re-stenosis (LTX- Stent Study) [NA]
The LTX-Stent Study investigating the influence of cirrhosis of the liver on coronary restenosis has been withdrawn.